National workshop on introduction of new TB drug in Kazakhstan

16–18 September 2014, Copenhagen, Denmark

In collaboration with the WHO Global TB Programme and KNCV Tuberculosis Foundation, the WHO/Europe Tuberculosis and M/XDR-TB Programme and the WHO Kazakhstan Country Office are organizing and will be carrying out a 3-day workshop on country-adapted introduction of a new TB drug named Bedaquiline. The outcome of the workshop will be a roadmap detailing adequate and feasible steps of Bedaquiline introduction taking into account country conditions and heightened demands on pharmacovigilance.